Globe Life, US37959E1029

JPMorgan raises target for Globe Life stock to USD 195

Published on 10/20/2026 at 20:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Second-quarter revenue reached USD 1.60 billion, up 8.00 percent year over year. Globe Life stock costs EUR 150.80 on October 20, 2026.

Analyst target and reporting date

  • JPMorgan revised its Globe Life target on October 15, 2026.
  • Second-quarter revenue reached USD 1.60 billion, up 8.00 percent year over year.
  • Globe Life stock cost EUR 150.80 at Lang & Schwarz on October 20, 2026 at 8:22 p.m. CEST.
  • Third-quarter results are scheduled for October 21, 2026.
Globe Life Inc. Pop-Art-Comic zeigt amerikanische Familie unter einem Versicherungsschutzschild, ISIN US37959E1029, Illustration mit AI erstellt.

Globe Life (ISIN US37959E1029) remains linked to JPMorgan's revised USD 195.00 price target, raised from USD 193.00 on October 15, 2026, according to MarketScreener. Globe Life was trading at EUR 150.80 at Lang & Schwarz on October 20, 2026 at 8:22 p.m. CEST.

Revenue rose in the second quarter

Globe Life reported second-quarter 2026 revenue of USD 1.60 billion, an 8.00 percent increase from the prior-year quarter. The company reported earnings per share of USD 3.61, below the USD 3.67 consensus estimate, while net margin was 19.58 percent, according to The Stock Observer.

Price position and valuation

The NYSE quote stood at USD 169.56 on October 20, 2026 at 2:28 p.m. EDT, up 1.02 percent from USD 167.85. Globe Life's market capitalization was USD 13.0 billion and its price-to-earnings ratio was 11.23 on the same quote. The 52-week range was USD 127.85 to USD 191.55.

What comes next for results

PR Newswire reported on October 19, 2026 that Globe Life will publish third-quarter 2026 results after the market closes on October 21, 2026. The company scheduled its conference call for October 22, 2026 at 11:00 a.m. ET. The calendar gives investors a near-term test for the USD 15.550 to USD 15.950 full-year 2026 earnings-per-share guidance cited by The Stock Observer.

Comparison with peers

Globe Life (NYSE, USD): up 1.02 percent, price-to-earnings ratio 11.23, market capitalization USD 13.0 billion.

Aflac (NYSE, USD): up 0.78 percent, price-to-earnings ratio 12.89, market capitalization USD 60.0 billion.

MetLife (NYSE, USD): up 1.35 percent, price-to-earnings ratio 19.37, market capitalization USD 64.1 billion.

Globe Life stock and the next session

JPMorgan's target is USD 25.44 above the NYSE quote of USD 169.56, a 15.00 percent difference calculated against the share price. Globe Life's second-quarter revenue growth provides the operating reference, while the October 21 results date provides the next company-specific event.

The further course of trading is shown by the continuously updated real-time quote of Globe Life stock.

Globe Life stock facts

  • Company: Globe Life Inc.
  • ISIN: US37959E1029
  • Ticker: GL
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 20, 2026, 8:22 p.m. CEST): EUR 150.80
  • Market capitalization: USD 13.0 billion (as of October 20, 2026)
  • Sector / Industry: Financial Services / Life Insurance

Market context: Market report S&P 500.

More news and analyses on Globe Life stock

Disclaimer...
en | US37959E1029 | GLOBE LIFE | boerse | 70377376 | bgmi